NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/25/2025
Back to search
Official data from USPTO
SANGAMO THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
11/26/2025
Trademark type
Combined
Nice classes
42
Filing date
12/28/2020
Registration date
11/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/25/2025
Last transaction
11/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2017-06-00
First use in commerce
2017-06-00
Drawing code
3
Owner type
03
Owner location
Richmond, CA
Examiner
LEE,REBECCA ANN
Law office
N40
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the wording "SANGAMO" in a stylized font with the letter "O" in "SANGAMO" comprised of two concentric circles with the outer circle being broken by two diagonal lines and the word "THERAPEUTICS" in a stylized font is centered below the letters "AMO" in the wording "SANGAMO".
Holders and representatives
Holders
Sangamo Therapeutics, Inc.
Sangamo Therapeutics, Inc.
Representatives
R. Gwen Peterson KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific research; technical scientific research and medical research consulting in the fields of bioinformatics and gene regulationgene modificationgene correction; product research and development of engineered proteins and nucleic acids for others; product design of genetic research tools and systems for others; custom product development of engineered proteins for use in gene editing
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/06/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/04/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/04/2025
ALIE
ASSIGNED TO LIE
11/04/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/29/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/29/2025
GNRT
NON-FINAL ACTION E-MAILED
07/29/2025
CNRT
SU - NON-FINAL ACTION - WRITTEN
07/29/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/01/2025
IUAF
USE AMENDMENT FILED
02/24/2025
EISU
TEAS STATEMENT OF USE RECEIVED
02/24/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/09/2024
EX5G
SOU EXTENSION 5 GRANTED
08/09/2024
EXT5
SOU EXTENSION 5 FILED
08/09/2024
EEXT
SOU TEAS EXTENSION RECEIVED
08/09/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/23/2024
EX4G
SOU EXTENSION 4 GRANTED
02/22/2024
EXT4
SOU EXTENSION 4 FILED
02/22/2024
EEXT
SOU TEAS EXTENSION RECEIVED
02/22/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/22/2023
EX3G
SOU EXTENSION 3 GRANTED
08/18/2023
EXT3
SOU EXTENSION 3 FILED
08/18/2023
EEXT
SOU TEAS EXTENSION RECEIVED
08/18/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/22/2023
EX2G
SOU EXTENSION 2 GRANTED
02/20/2023
EXT2
SOU EXTENSION 2 FILED
02/20/2023
EEXT
SOU TEAS EXTENSION RECEIVED
02/20/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
02/15/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/15/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
02/15/2023
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
09/22/2022
EX1G
SOU EXTENSION 1 GRANTED
09/21/2022
IROA
RESPONSE TO ITU OFFICE ACTION ENTERED
09/19/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/19/2022
INCE
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
09/15/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/15/2022
EXT1
SOU EXTENSION 1 FILED
08/22/2022
FAXX
FAX RECEIVED
08/22/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/22/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/22/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/22/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/22/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/28/2021
PUBO
PUBLISHED FOR OPPOSITION
12/28/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/08/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/23/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
11/15/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
11/15/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/15/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/30/2021
GNRT
NON-FINAL ACTION E-MAILED
06/30/2021
CNRT
NON-FINAL ACTION WRITTEN
06/30/2021
DOCK
ASSIGNED TO EXAMINER
06/24/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
03/18/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
03/17/2021
NWAP
NEW APPLICATION ENTERED
12/31/2020
Continuous trademark protection
Get notified about every new filing that threatens SANGAMO THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.